Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one chemotherapy drug may kill more tumor
cells.
PURPOSE: Phase I trial to study the effectiveness of capecitabine combined with cisplatin in
treating patients who have locally advanced or metastatic solid tumors .
Phase:
Phase 1
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health